USPTO trademark

FINQUEST

AbandonedUSPTOWord markClass 1Class 5Class 9Class 42

"FINQUEST" is a word mark owned by Genome Therapeutics Corporation, filed at the USPTO on February 29, 2000. It was abandoned and covers classes 1, 5, 9 and 42.

View Genome Therapeutics Corporation portfolioGet this data via the API
Official USPTO record
FINQUEST trademark as filed
As filed with the USPTO
Status
Abandoned
Since May 20, 2003
Filed
February 29, 2000
Registered
Not yet
Expires
Not recorded
Application no.
75931689
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
4 classes
Ownership

Who owns FINQUEST

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Genome Therapeutics Corporation

Waltham, United States

26 trademarks in the portfolioView company

Representative

Fred W. Hathaway

Burns, Doane, Swecker & Mathis, LLP

Goods and services

What the mark covers

The products and services FINQUEST is filed for, grouped by Nice class.

  • Chemicals, namely, therapeutic agents in the nature of genomic drugs, polypeptides, proteins and genes for use in the pharmaceutical industry

  • Therapeutic agents, namely, drugs, polypeptides, deoxyribonucleic acid (DNA), proteins and genes for use in the treatment of human diseases and disorders

  • Computer software, featuring a database used for genetic or protein analysis; computer hardware and computer peripherals

  • Biotechnology research and development services in the field of genomic research, namely drug development and repositioning; designing clinical trials; genomic sequencing and finishing, single nucleotide polymorphism (SNP) detection and haplotyping, providing genomic, polypeptide and protein information; generating genomes; pharmocogenomics, diagnostics and therapeutics pertaining to disease states and conditions

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Abandonment - after inter partes decision
  2. Opposition terminated no. 999999
  3. Opposition sustained no. 999999
  4. Opposition instituted no. 999999
  5. Extension of time to oppose received
  6. Published for opposition
  7. Notice of publication
  8. Approved for pub - principal register
  9. Correspondence received in law office
  10. Non-final action mailed

4 earlier steps on the official record.

Disputes

Oppositions and cancellations

Proceedings recorded against this mark by the USPTO. Reported as recorded, not legal advice.

FAQ

About FINQUEST

Who owns the trademark "FINQUEST"?

The USPTO trademark "FINQUEST" (application 75931689) is owned by Genome Therapeutics Corporation.

What is the status of "FINQUEST"?

Its status at the USPTO is: abandoned.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull FINQUEST and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d1dab-de50-749b-87ca-0f2f9ca1d18a
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d1dab-de50-749b-87ca-0f2f9ca1d18a",
  "object": "trademark",
  "mark_text": "FINQUEST",
  "status": {
    "primary": "inactive",
    "stage": "abandoned"
  },
  "office_code": "US",
  "application_number": "75931689",
  "filing_date": "2000-02-29",
  "nice_classes": [
    1,
    5,
    9,
    42
  ],
  "owners": [
    {
      "name": "Genome Therapeutics Corporation",
      "entity_id": "ent_01a10e24-b8e2-70de-8904-e706bb21f26e"
    }
  ]
}